Mirion's Q3 Shows Demand Surge but Margin Target Abandoned

What happened

Mirion's Q3 earnings call revealed a 24.5% year-over-year revenue jump and sharply higher orders, driven by accelerating nuclear demand. Management responded by raising its 2026 revenue and free-cash-flow guidance. However, the company simultaneously lowered the high end of adjusted EBITDA guidance and withdrew its 2028 margin target. This suggests that growth is coming with thinner profitability, likely due to Paragon integration or a mix shift toward lower-margin projects. The demand trajectory is positive, but the margin retreat undercuts the long-term profit expansion story that supported a premium valuation.

Implication

Near-term, the raised FCF guidance provides some de-risking for the balance sheet, but the trimmed EBITDA high end means cash conversion may come from working capital or timing rather than structural margin improvement. The withdrawal of the 2028 margin target removes a key anchor for long-term earnings power, forcing a re-rating of the stock's premium multiple. With EV/EBITDA still around 28x on lowered margin expectations, the risk/reward remains unattractive. We would need concrete evidence of margin stabilization or new large order disclosures that carry higher-margin work to reconsider the cautious stance. Until then, we maintain a WAIT and prefer entry near $19 as previously outlined.

Thesis delta

The prior thesis required Mirion to deliver FCF and sustain margins while integrating Paragon; Q3's strong orders and raised FCF guidance partially de-risk the near-term cash picture. However, the withdrawal of the 2028 margin target and lowered EBITDA high end mean profitability expectations must be revised downward. This shifts the bull case from 'revenue growth with margin expansion' to 'revenue growth with margin compression,' which is less compelling at a 28x EV/EBITDA multiple.